Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Viscosity of Submucosal Gel Injections in EMR
NCT02519140Phase 3Withdrawn
- Start
- Aug 2014
- Primary completion
- Nov 2022
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial. Primary endpoint: Lift Efficacy at 1 hour. Planned start Aug 2014; status: withdrawn.
Beyond the preview
Go deeper on NCT02519140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02519140.